For all press and media enquiries please contact mediarelations@chiesi.com
Key Highlights from 2024: Patients: Invested €829 million in R&D; opened Parma Biotech Center of Excellence; Health Equity initiatives now active in 33 countries; expanded efforts to improve access to neonatal treatments in low-income countries. Planet: Published Climate Transition Plan reinforcing…
Chiesi is the only European pharmaceutical company and the first Italian company ever to be included in the World’s Best Workplaces™ The accolade reflects Chiesi's dedication to people’s well-being, continuous improvement, and creating a positive work environment Chiesi was also recently ranked in…
Chiesi Group's Sustainability Report 2023 highlights impacts on strategic areas such as Patients, Planet, People and Prosperity while anticipating regulatory changes. Patients: Chiesi invested 23.8% of its revenues in research and development and advocated for patients with respiratory conditions,…
Chiesi’s Sustainability Report 2022 is released today; The company has committed to reaching Net Zero GHG emissions by 2035; 130,000 units of Chiesi medicines, valued at €4.5 million, were donated to patients in conflict territories; The company closed the gender pay gap at Group level, with an…
Chiesi Group has been named on Carbon Disclosure Project’s Climate Change A List for its commitment to climate action and transparency. The Group has also received from Cerved Rating Agency the AA ESG rating with an overall score of 75.1 out of 100. According to the independent rating agency, Chiesi…
The Group has increased its B-Impact score by 16.3 points, with 103.8 out of 200 compared to its first certification in 2019; The recertification process by B Lab identifies further focus for action and continuous improvement. Parma (Italy) September 22 nd, 2022 – The B Corp movement, established to…
Chiesi’s Annual and Sustainability Report 2021 is released today; Progress towards business, environmental and social targets is strong; Company is joining forces with all stakeholders to advance sustainable healthcare. Parma (Italy) July 14 th, 2022 – Chiesi, the international research-focused…
You are leaving the Chiesi Corp site to access another Chiesi site. Regulatory constraints and medical practices, as well as the information published on the site you are about to visit, may change from one country to another and may not comply with current Italian legislation on the subject.
You are about to leave our website and access an external site. By continuing, you agree to leave our site.
